Literature DB >> 23039999

Clinical significance and management of sentinel node micrometastasis in invasive breast cancer.

Sadaf Jafferbhoy1, Billy McWilliams.   

Abstract

Axillary node status is one of the most important prognostic indicators in patients with invasive breast cancer. Sentinel node biopsy allows an exhaustive examination of the lymph node and has led to an increased detection rate of small tumor deposits. Patients with micrometastatic deposits can have nonsentinel node involvement, including macrometastatic deposits. Sentinel node micrometastases are associated with an adverse impact on disease recurrence and survival. Axillary dissection does not offer an advantage in reducing the incidence of disease recurrence or survival. However, the long-term outcomes can be improved with the use of adjuvant chemotherapy, and it would be reasonable to consider systemic treatment in these patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23039999     DOI: 10.1016/j.clbc.2012.07.012

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  11 in total

Review 1.  Sentinel lymph node in endometrial cancer: a review.

Authors:  Cyril Touboul; Enrica Bentivegna; Catherine Uzan; Sebastien Gouy; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Christine Haie-Meder; Philippe Morice
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.

Authors:  A Eisen; G G Fletcher; S Gandhi; M Mates; O C Freedman; S F Dent; M E Trudeau
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

3.  An intra-operative RT-LAMP method allows rapid and reliable detection of sentinel lymph node metastasis in breast cancer patients.

Authors:  Xiaopeng Hao; Yi Liu; Xiru Li; Hua Kang; Xiang Qu; Jianmiao He; Haixu Hu; Yan Huang; Bing Liu; Chengze Yu
Journal:  Virchows Arch       Date:  2014-11-27       Impact factor: 4.064

4.  Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?

Authors:  A Tavares; X Wen; J Maciel; F Carneiro; M Dinis-Ribeiro
Journal:  Ann Surg Oncol       Date:  2020-05-04       Impact factor: 5.344

5.  Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

Authors:  Johannes Bargehr; Michael Edlinger; Michael Hubalek; Christian Marth; Roland Reitsamer
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

6.  Clinical significance of molecular diagnosis for gastric cancer lymph node micrometastasis.

Authors:  Hiromichi Sonoda; Tohru Tani
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

7.  In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.

Authors:  Ildiko Illyes; Anna-Maria Tokes; Attila Kovacs; A Marcell Szasz; Bela A Molnar; Istvan A Molnar; Ilona Kaszas; Zsuzsanna Baranyak; Zsolt Laszlo; Istvan Kenessey; Janina Kulka
Journal:  Virchows Arch       Date:  2014-05-09       Impact factor: 4.064

8.  Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.

Authors:  Roi Weiser; Efstathia Polychronopoulou; Waqar Haque; Sandra S Hatch; Jing He; Suimin Qiu; Avi Markowitz; William J Gradishar; Yong-Fang Kuo; V Suzanne Klimberg
Journal:  Ann Surg Oncol       Date:  2021-07-11       Impact factor: 5.344

9.  Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes.

Authors:  Feng Liang; Hongzhu Qu; Qiang Lin; Yadong Yang; Xiuyan Ruan; Bo Zhang; Yi Liu; Chengze Yu; Hongyan Zhang; Xiangdong Fang; Xiaopeng Hao
Journal:  World J Surg Oncol       Date:  2015-08-28       Impact factor: 2.754

10.  Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.

Authors:  Yoshiaki Shinden; Hiroki Ueo; Taro Tobo; Ayako Gamachi; Mitsuaki Utou; Hisateru Komatsu; Sho Nambara; Tomoko Saito; Masami Ueda; Hidenari Hirata; Shotaro Sakimura; Yuki Takano; Ryutaro Uchi; Junji Kurashige; Sayuri Akiyoshi; Tomohiro Iguchi; Hidetoshi Eguchi; Keishi Sugimachi; Yoko Kubota; Yuichiro Kai; Kenji Shibuta; Yuko Kijima; Heiji Yoshinaka; Shoji Natsugoe; Masaki Mori; Yoshihiko Maehara; Masayo Sakabe; Mako Kamiya; John W Kakareka; Thomas J Pohida; Peter L Choyke; Hisataka Kobayashi; Hiroaki Ueo; Yasuteru Urano; Koshi Mimori
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.